Rare diseases
Investigational molecules
Locations
Back to Bulgaria8 clinical trials in Novi Iskar, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia
BulgariaEfficacy, Safety, and Tolerability of NBI-1065890 in Adults with Tardive Dyskinesia
BulgariaEfficacy and safety of roluperidone versus drug combination in adults with schizophrenia with negative symptoms
BulgariaA study testing xanomeline tartrate and trospium chloride added to current treatment for adults with bipolar I disorder experiencing mania
BulgariaLong-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) for treatment of manic episodes in adults with Bipolar I Disorder
BulgariaStudy of trospium chloride and xanomeline tartrate (KarXT) for treatment of manic episodes in adults with bipolar I disorder
BulgariaLong-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) in patients with inadequately controlled schizophrenia symptoms
BulgariaStudy of KarXT (trospium chloride and xanomeline tartrate) in patients with inadequately controlled schizophrenia symptoms
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on schizophrenia treatment are currently underway, investigating new therapeutic approaches for patients with inadequately controlled symptoms.
These studies evaluate novel adjunctive therapies using the Positive and Negative Syndrome Scale to measure treatment effectiveness, aiming to improve patient outcomes in psychiatric care.
Research initiatives are exploring combination therapy approaches for individuals whose schizophrenia symptoms are not adequately controlled by current treatments.
The research encompasses both immediate efficacy assessment and extended monitoring to ensure sustainable therapeutic benefits.
Comprehensive investigations of adjunctive treatments are being conducted to establish both immediate and long-term safety profiles for new therapeutic interventions.
These trials include rollover studies to gather extended safety data and evaluate ongoing treatment effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
